Emerging Therapies for Advanced Clear Cell Renal Cell Carcinoma
Multiple combinational regimens have recently been approved and are now considered the standard of care for patients with advanced clear cell renal cell carcinoma (RCC). Several additional combinational regimens are deep in clinical assessment and are likely to soon join the crowded front-line thera...
Main Authors: | Alexander T. Toth, Daniel Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2020-12-01
|
Series: | Journal of Kidney Cancer and VHL |
Subjects: | |
Online Access: | https://jkcvhl.com/index.php/jkcvhl/article/view/156 |
Similar Items
-
Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma
by: Luisa M. Cardenas, et al.
Published: (2022-07-01) -
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What’s the Story Morning Glory?
by: Andrea Marchetti, et al.
Published: (2021-06-01) -
Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
by: Kevin K. Zarrabi, et al.
Published: (2022-09-01) -
Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
by: Manon Teisseire, et al.
Published: (2024-02-01) -
Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade
by: Mathieu Larroquette, et al.
Published: (2022-12-01)